EUVIMEDEUVIMED entdecken
Crossref

miR-26b-modified human umbilical cord mesenchymal stem cells exhibit enhanced anti-fibrotic efficacy in a mouse model of hepatic fibrosis

Jianwei Xu, Lihong He, Jingxia Xu, Xiuzhen Yang, Wanhang Deng, Can Liu, Li Yuan, Xuxian Wu, Huanxiang Zhang

Molecular Biology Reports · 2026-12 · 53 (1)

DOI: 10.1007/s11033-026-12414-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 10.08.2026. Verfasst von Jianwei Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for tissue Engineering and Stem Cell Research, Guizhou Medical University, Gui 'an New District, 561113, China. Hauptthemen laut MEDLINE: MicroRNAs, Mesenchymal Stem Cells, Liver Cirrhosis, Mesenchymal Stem Cell Transplantation. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMesenchymal Stem CellsLiver CirrhosisMesenchymal Stem Cell TransplantationAnimalsHumansMiceUmbilical CordDisease Models, AnimalApoptosisCell MovementMaleLiverCell Survival

Stichwörter der Autor:innen

Anti-fibrosis efficacyHuman umbilical cord mesenchymal stem cellsLiver fibrosisMigrationmiR-26b

Substanzen

MicroRNAsMIRN26 microRNA, human

Autor:innen und Institutionen

  • Center for tissue Engineering and Stem Cell Research, Guizhou Medical University, Gui 'an New District, 561113, China.
  • Department of Pharmacology, School of Basic Medicine, Guizhou Medical University, Gui 'an New District, 561113, China.
  • Department of Cell Biology, MOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Medical College of Soochow University, Suzhou, 215123, China.
  • Department of Gastroenterology, Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China.
  • Guizhou Provincial Key Laboratory for Digestive System Diseases, the Affiliated Hospital of Guizhou Medical University, Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China.
  • Guizhong Biotechnology Co., Ltd, Guiyang, 550081, China.

Zitieren

APA

Xu, J., He, L., Xu, J., Yang, X., Deng, W., Liu, C., Yuan, L., Wu, X., & Zhang, H. (2026). miR-26b-modified human umbilical cord mesenchymal stem cells exhibit enhanced anti-fibrotic efficacy in a mouse model of hepatic fibrosis. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-12414-5

Vancouver

Xu J, He L, Xu J, Yang X, Deng W, Liu C, et al. miR-26b-modified human umbilical cord mesenchymal stem cells exhibit enhanced anti-fibrotic efficacy in a mouse model of hepatic fibrosis. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-12414-5

BibTeX
@article{Xu2026,
  author = {Xu, Jianwei and He, Lihong and Xu, Jingxia and Yang, Xiuzhen and Deng, Wanhang and Liu, Can and Yuan, Li and Wu, Xuxian and Zhang, Huanxiang},
  title = {miR-26b-modified human umbilical cord mesenchymal stem cells exhibit enhanced anti-fibrotic efficacy in a mouse model of hepatic fibrosis},
  journal = {Molecular Biology Reports},
  year = {2026},
  volume = {53},
  number = {1},
  doi = {10.1007/s11033-026-12414-5}
}
Kostenlos starten →